Jay Mazelsky’s stock holdings have seen notable fluctuations over the years, particularly during a robust growth phase for IDEXX Laboratories. His wealth, tied closely to the company’s stock performance, peaked in June 2021 at around $37 million. However, this wealth...

Jay Mazelsky’s stock holdings have seen notable fluctuations over the years, particularly during a robust growth phase for IDEXX Laboratories. His wealth, tied closely to the company’s stock performance, peaked in June 2021 at around $37 million. However, this wealth was subject to significant variations, showing both the highs and lows of the stock market. For instance, in December 2022, his holdings valued around $29 million, illustrating the volatility inherent in stock ownership. His trading patterns reflect both the performance of IDEXX and his personal financial strategy, marking a journey that closely mirrors the company’s broader market narrative.